资讯

Marty Makary says the FDA will plow ahead with big plans on ultra processed foods, dietary guidelines, and expedited drug and ...
A deep dive into the implications of the Replimune CRL that surprised insiders and investors, the role of new leadership at ...
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
While FDA Commissioner Marty Makary emphasizes learning and humility, the FDA has systematically removed the very experience ...
The FDA will select at most five companies that align with national priorities, including lower drug prices and increased ...
The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...
FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and ...
The manufacturing-related rejection for UX111 is more than a setback for Ultragenyx, as it also delays a key test of the new ...
Despite recent staffing reductions and leadership transitions at the FDA, pharmaceutical and medical device manufacturers should not interpret these changes as a signal of reduced regulatory ...
Amna Nawaz: In a significant shift this week, Health Secretary Robert F. Kennedy, Jr., joined by FDA Commissioner Dr. Martin Makary and NIH Director Dr. Jay Bhattacharya, announced that COVID-19 ...
COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...